|

NMRA-335140 Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: BTRX 335140, BTRX-335140, CYM-53093, Navacaprant

Pipeline

Phase 3: 3

Top Sponsors

  • Neumora Therapeutics, Inc.3

Indications

  • Major Depressive Disorder3
  • Depression3

Huntsville, Alabama1 trial

Study to Assess the Safety and Effectiveness of NMRA-335140-501

Neumora Investigator site

Phase 3

Cerritos, California1 trial

Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder

Neumora Investigator Site

Phase 3

Encino, California1 trial

Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

Neumora Investigator Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.